Hematology Special Issue | CURE

Patient-Reported Outcomes and Quality-of-Life Measures in Myeloid Disease Can Help Inform Treatment Decisions

March 16, 2016


Two posters presented at the annual meeting of the American Society of Hematology discussed patient-reported outcome measures and quality-of-life indicators as supportive tools for treatment in individuals being treated for acute myeloid leukemia and myelodysplastic syndrome.